Wednesday, March 29, 2023

Tag: investigational vaccine candidates (BNT162b1 and BNT162b2)


Pfizer & Biontech announce agreement with Britain for 30 million doses...

Pfizer and BioNTech remain on track to begin an anticipated Phase 2b/3 safety and efficacy trial later this month, seek regulatory review as early...

This function has been disabled for HealthTekPak.

error: Content is protected !!